Why aren't drugs to prevent breast cancer better known in the US?

A newly U.K.-approved drug, anastrozole, is one of three drugs available in the U.S. for people at risk of developing breast cancer. 

November 14, 2023 Check out STAT+

Sponsored By

Damian Dovarganes/AP The U.K. just cleared a drug to prevent breast cancer. U.S. women may not know it's already an option Women in the US may not know that the drug anastrozole is one of three that can be prescribed to people at risk of breast cancer. By Elizabeth Cooney STAT+ | FDA cites cancer links in seeking to withdraw approval of antibiotic used in pigs The concern is that carcinogenic traces of the medicine can find their way into humans through pork in the food supply chain. By Ed Silverman STAT+ | A Harvard-affiliated hospital is testing magic mushrooms on dying patients Dana-Farber Cancer Institute's Psychedelic-Assisted Therapy program is testing impact of magic mushrooms on mental health of dying patients. By Jonathan Saltzman — Boston Globe

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser